Comprehensive Post-COVID Care Now Available! Click here to learn more.
Eris COVID Variant

Decoding Threats: ‘Eris’ The Latest COVID Variant

In the ongoing battle against the COVID-19 pandemic, new challenges continue to emerge as a threat to our health worldwide. Now the latest coronavirus-related concern on the global stage is the latest COVID variant EG.5 ‘Eris’ – a term that has sparked conversations, curiosity, and concerns alike.

As a trusted healthcare provider, Manhattan Medical Arts believes in providing the most accurate and up-to-date information on all health-related concerns to help you navigate these uncertain times and newly occurring threats.

In today’s blog, we’ll discuss the new strain of COVID EG.5, unofficially named ‘Eris’ – exploring the latest COVID symptoms, its characteristics, and more.

Understanding the Eris Variant

Since the COVID news came out, everyone has been eager and asking “What is the new strain of covid?” – and we’re here to explain dominant COVID variant in US.

The ‘Eris’ variant, officially known as EG.5, has recently gained attention due to its potential impact on the spread of COVID-19. Originating from a combination of mutations, this variant has raised concerns among health officials and experts worldwide. According to the WHO, as of 7th August 2023, this EG.5 variant of omicron has already affected as many as 51 countries.

Key Characteristics of New COVID Variant

This new COVID variant is characterized by a unique combination of mutations in the spike protein of the virus, which is the primary target for vaccines and antibodies. Preliminary data has suggested that some of these mutations may impact transmissibility and immune evasion, potentially affecting the effectiveness of current vaccines and therapies.

Symptoms of Eris Variant

While research on the EG.5 is still ongoing, reports from affected regions all over the world show that symptoms of EG.5 are quite similar to the original COVID-19 strain, including:

  • Fever: A high temperature, often accompanied by chills or sweating.
  • Cough: A dry cough that can be persistent and irritating.
  • Fatigue: Extreme tiredness and lack of energy.
  • Loss of Taste or Smell: A sudden loss of your ability to taste and smell.
  • Muscle or Body Aches: General body discomfort or aches.
  • Sore Throat: Irritation or scratchiness in the throat.
  • Headache: Aching head or pressure in the temples.
  • Congestion or Runny Nose: The nasal symptoms of new COVID variant are similar to that of a cold.
  • Nausea or Vomiting: Feeling sick to your stomach or vomiting.
  • Diarrhea: Frequent, loose, or watery stools.

It’s crucial to note that the new variant symptoms may vary widely and some individuals might remain asymptomatic.

How Is EG.5 Different From Other Recent Coronavirus Strains?

EG.5, identified in February, is a new form of the Omicron variant. It has a slight genetic difference, making it a bit different from previous versions, but its not all that different. However, this change could impact immunity from infection or vaccination.

The World Health Organization calls it a “variant of interest,” meaning it needs close monitoring for potential increased contagion or severity.

Latest Updates and Cases

In order to maintain health and remain safe from this newly introduced threat, staying informed about the latest developments in the EG.5 variant landscape is immensely important. Regularly check reliable sources such as the WHO (World Health Organization) for updates on variant spread, case numbers, and recommended precautions.

Several countries have reported cases of the EG.5 variant, prompting global health organizations to closely monitor its progression.

How prevalent is EG.5?

“As of 7 August 2023, 7354 sequences of EG.5 have been submitted to GISAID from 51 countries. The largest portion of EG.5 sequences are from China (30.6%, 2247 sequences). The other countries with at least 100 sequences are the United States of America (18.4%, 1356 sequences), the Republic of Korea (14.1%, 1040 sequences), Japan (11.1%, 814 sequences), Canada (5.3%, 392 sequences), Australia (2.1%, 158 sequences), Singapore (2.1%, 154 sequences), the United Kingdom (2.0%, 150 sequences), France (1.6%,119 sequences), Portugal (1.6%, 115 sequences), and Spain (1.5%, 107 sequences).

Globally, there has been a steady increase in the proportion of EG.5 reported. During epidemiological week 29 (17 to 23 July 2023), the global prevalence of EG.5 was 17.4%. This is a notable rise from the data reported four weeks prior (week 25, 19 to 25 June 2023), when the global prevalence of EG.5 was 7.6%.”

Staying Safe and Informed

Amid the evolving situation, it’s imperative to prioritize safety. Continue practicing preventive measures such as wearing masks, practicing good hand hygiene, and adhering to local health guidelines.

Additionally, staying informed through trusted sources such as Manhattan Medical Arts, that is dedicated towards consistently keeping you informed and updated, will empower you to make informed decisions about your health and the well-being of your loved ones.

Conclusion – Your Health, Our Priority

At Manhattan Medical Arts, we are committed to ensuring your health and safety in the face of emerging challenges like the EG.5 variant of COVID. Our team of dedicated medical professionals is here to provide expert guidance, answer your questions, and offer the support you need during these times. Remember, knowledge is a powerful tool – by staying informed and following recommended precautions, we can collectively navigate through this challenging phase and emerge stronger.

For the most accurate and timely information, we encourage you to visit the World Health Organization’s official website: [].

For personalized guidance and medical care, don’t hesitate to reach out to us at or book an appointment to visit and consult our experts in person.

Frequently Asked Questions

How different are EG.5 and HV.1 to previous omicron subvariants?

EG.5 and HV.1 are sub-variants of the Omicron variant with certain specific genetic changes.

Is the new COVID vaccine still effective against EG.5 and HV.1?

The effectiveness of the new COVID vaccine against EG.5 and HV.1 is still being extensively studied and keeping an eye on the latest updates from health authorities is crucial.

However, HV.1 has descended from EG.5 and is very similar to it – while there isn’t concrete data regarding the performance of new vaccines against HV.1, but the head of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, Dr. Dan Barouch has explained that its effect will be just as it has been against EG.5.

COVID PCR testing site near me

For anyone seeking COVID PCR testing in NYC, Manhattan Medical Arts as the best option for COVID PCR as well as other testing/screenings.

What are the symptoms of EG.5 variant?

While the new COVID variant symptoms are still being further studied, they may include the common COVID 19 symptoms like cough, fever, fatigue, headache, diarrhea, nausea, and more.

Can COVID tests detect EG.5?

Standard COVID testing can surely detect EG.5, but specific testing may be required to confirm and verify the specific variant.

What’s the newest strain of Covid?

EG.5 variant is one of the latest identified variants of the SARS-CoV-2 virus.

How long does EG.5 variant last?

The duration of EG.5 is still under investigation, and may vary for different individuals depending on the severity of new strain of covid symptoms. Consult health authorities for the latest information.

How many times can you get COVID?

There’s no set limit on how many times one can get COVID; appropriately administered vaccinations and gain in immunity due to previous infection can offer some protection. Regular preventive measures are crucial.

What is the incubation period for covid?

The incubation period for COVID is typically 2 to 14 days, with most cases showing new COVID strain symptoms around 4-5 days after exposure.


– Disclaimer –
This blog is for informational & educational purposes only, and does not intend to substitute any professional medical advice or consultation. For any health related concerns, please consult with your physician, or call 911.

Medically Reviewed

Last reviewed by Dr. Syra Hanif, M.D. on 08/24/2023

Learn more about our editorial process.

  • About The Author

    Dr. Syra Hanif M.D.

    Board Certified Primary Care Physician

Dr. Syra Hanif is a board-certified Primary Care Physician (PCP) dedicated to providing compassionate, patient-centered healthcare.

Read More